TOWA PHARMACEUTICAL CO.,LTD. Logo

TOWA PHARMACEUTICAL CO.,LTD.

Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.

4553 | T

Overview

Corporate Details

ISIN(s):
JP3623150004
LEI:
Country:
Japan
Address:
門真市新橋町2番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and accessible medications. Its product portfolio encompasses a wide range of therapeutic areas, including drugs for the nervous system, digestive system, and allergic diseases, in addition to vitamins and antibiotics. The company focuses on formulation development to enhance its product offerings and contributes to healthcare by making essential medicines more widely available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 08:01
Regulatory News Service
臨時報告書
Japanese 24.0 KB
2025-06-24 05:01
Governance Information
内部統制報告書-第69期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-24 05:00
Annual Report
有価証券報告書-第69期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-06-24 05:00
Registration Form
確認書
Japanese 8.1 KB
2024-11-13 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-13 01:00
Interim Report
半期報告書-第69期(2024/04/01-2025/03/31)
Japanese 207.6 KB
2024-07-10 09:04
Registration Form
確認書
Japanese 8.1 KB
2024-07-10 09:00
Annual Report
訂正有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 849.4 KB
2024-06-27 05:54
Post-Annual General Meeting Information
臨時報告書
Japanese 24.9 KB
2024-06-26 02:02
Regulatory News Service
内部統制報告書-第68期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-26 02:01
Regulatory News Service
確認書
Japanese 8.1 KB
2024-06-26 02:01
Annual Report
有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 1.4 MB
2024-02-14 01:01
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-02-14 01:00
Quarterly Report
四半期報告書-第68期第3四半期(2023/10/01-2023/12/31)
Japanese 169.1 KB
2023-11-14 01:00
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all TOWA PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TOWA PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TOWA PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Acurx Pharmaceuticals, Inc. Logo
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
United States of America ACXP
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America ADAG
Adaptimmune Therapeutics PLC Logo
Develops novel T-cell therapies to treat solid tumors by engineering a patient's own immune cells.
United States of America ADAP
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea 179530
ADC Therapeutics SA Logo
Develops targeted antibody-drug conjugates for hematological and solid tumors.
United States of America ADCT
Addex Therapeutics Ltd. Logo
Developing novel oral allosteric modulators to treat neurological disorders.
United States of America ADXN
ADIAL PHARMACEUTICALS, INC. Logo
Develops personalized, genetically-targeted drugs for treating Alcohol Use Disorder and addiction.
United States of America ADIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.